O	0	9	Incidence
O	10	12	of
B-Disease	13	27	postvitrectomy
I-Disease	28	35	macular
I-Disease	36	41	edema
O	42	47	using
B-Diagnostic_tool	48	55	optical
I-Diagnostic_tool	56	65	coherence
I-Diagnostic_tool	66	76	tomography
O	76	77	.

O	79	81	To
O	82	90	evaluate
O	91	94	the
O	95	104	incidence
O	104	105	,
O	106	112	effect
O	113	115	on
O	116	122	visual
O	123	131	recovery
O	131	132	,
O	133	136	and
O	137	149	predisposing
O	150	154	risk
O	155	162	factors
O	163	165	of
B-Disease	166	180	postvitrectomy
I-Disease	181	188	macular
I-Disease	189	194	edema
O	195	196	(
B-Disease	196	198	ME
O	198	199	)
O	199	200	.

O	201	212	Prospective
O	213	219	cohort
O	220	225	study
O	225	226	.

O	227	230	One
O	230	231	-
O	231	238	hundred
O	239	243	nine
B-Anatomy	244	248	eyes
O	249	259	undergoing
O	260	271	nonemergent
O	272	282	vitrectomy
O	283	290	surgery
O	290	291	.

B-Anatomy	292	296	Eyes
O	297	301	were
O	302	311	evaluated
O	312	315	for
O	316	329	postoperative
O	330	333	day
O	334	335	1
B-Symptom	336	348	inflammation
O	348	349	,
O	350	351	1
O	351	352	-
O	352	357	month
B-Characteristic	358	365	retinal
I-Characteristic	366	375	thickness
O	376	381	using
B-Diagnostic_tool	382	389	optical
I-Diagnostic_tool	390	399	coherence
I-Diagnostic_tool	400	410	tomography
O	410	411	,
O	412	415	and
O	416	428	preoperative
O	429	432	and
O	433	434	1
O	434	435	-
O	435	440	month
O	441	454	postoperative
B-Characteristic	455	459	best
I-Characteristic	459	460	-
I-Characteristic	460	469	corrected
I-Characteristic	470	476	visual
I-Characteristic	477	483	acuity
O	484	485	(
B-Characteristic	485	489	BCVA
O	489	490	)
O	490	491	.

B-Disease	492	499	Macular
I-Disease	500	505	edema
O	506	509	was
O	510	517	defined
O	518	520	as
B-Symptom	521	528	central
I-Symptom	529	537	subfield
I-Symptom	538	547	thickness
B-Dimension	549	550	>
I-Dimension	552	554	or
I-Dimension	555	556	=
I-Dimension	556	559	272
I-Dimension	560	566	microm
O	566	567	.

B-Characteristic	568	575	Retinal
I-Characteristic	576	585	thickness
O	585	586	,
B-Symptom	587	599	inflammation
O	599	600	,
O	601	604	and
B-Characteristic	605	609	BCVA
O	609	610	.

O	611	620	Incidence
O	621	623	of
B-Disease	624	626	ME
O	627	629	on
B-Diagnostic_tool	630	637	optical
I-Diagnostic_tool	638	647	coherence
I-Diagnostic_tool	648	658	tomography
O	659	662	was
O	663	665	47
O	665	666	%
O	667	668	(
O	668	670	95
O	670	671	%
O	672	682	confidence
O	683	691	interval
O	692	693	[
O	693	695	CI
O	695	696	]
O	696	697	,
O	698	700	37
O	700	701	%
O	701	702	-
O	702	704	56
O	704	705	%
O	705	706	)
O	706	707	.

O	708	712	Mean
O	713	714	1
O	714	715	-
O	715	720	month
B-Characteristic	721	727	visual
I-Characteristic	728	734	acuity
O	735	743	improved
O	744	745	3
O	745	746	.
O	746	747	3
O	748	753	lines
O	754	755	(
O	755	756	0
O	756	757	.
O	757	759	33
O	760	769	logarithm
O	770	772	of
O	773	780	minimum
O	781	786	angle
O	787	789	of
O	790	800	resolution
O	801	802	[
O	802	808	logMAR
O	808	809	]
O	811	816	units
O	816	817	)
O	818	820	to
O	821	823	20
O	823	824	/
O	824	826	80
O	826	827	(
O	827	828	+
O	828	829	1
O	829	830	)
O	831	832	(
O	832	833	0
O	833	834	.
O	834	836	58
O	836	837	+
O	837	838	/
O	838	839	-
O	839	840	0
O	840	841	.
O	841	843	46
O	844	850	logMAR
O	851	856	units
O	856	857	)
O	858	862	from
O	863	865	20
O	865	866	/
O	866	869	150
O	869	870	(
O	870	871	-
O	871	872	2
O	872	873	)
O	874	875	(
O	875	876	0
O	876	877	.
O	877	879	91
O	879	880	+
O	880	881	/
O	881	882	-
O	882	883	0
O	883	884	.
O	884	886	63
O	887	893	logMAR
O	894	899	units
O	899	900	)
O	901	907	before
O	908	915	surgery
O	916	917	(
O	917	918	P
O	919	920	<
O	921	922	0
O	922	923	.
O	923	926	001
O	926	927	)
O	927	928	.

O	929	933	Mean
O	934	935	1
O	935	936	-
O	936	941	month
B-Characteristic	942	948	center
I-Characteristic	949	954	point
I-Characteristic	955	964	thickness
O	965	966	(
B-Characteristic	966	969	CPT
O	969	970	)
O	970	971	,
B-Characteristic	972	979	central
I-Characteristic	980	988	subfield
O	989	990	(
B-Characteristic	990	993	CSF
O	993	994	)
O	994	995	,
O	996	999	and
B-Characteristic	1000	1005	total
I-Characteristic	1006	1013	macular
I-Characteristic	1014	1020	volume
O	1021	1025	were
O	1026	1029	265
O	1029	1030	+
O	1030	1031	/
O	1031	1032	-
O	1032	1035	107
O	1036	1042	microm
O	1042	1043	,
O	1044	1047	288
O	1047	1048	+
O	1048	1049	/
O	1049	1050	-
O	1050	1052	94
O	1053	1059	microm
O	1059	1060	,
O	1061	1064	and
O	1065	1066	7
O	1066	1067	.
O	1067	1068	8
O	1068	1069	+
O	1069	1070	/
O	1070	1071	-
O	1071	1072	1
O	1072	1073	.
O	1073	1074	2
O	1075	1077	mm
O	1077	1078	(
O	1078	1079	3
O	1079	1080	)
O	1080	1081	,
O	1082	1094	respectively
O	1094	1095	.

O	1096	1104	Severity
O	1105	1107	of
B-Symptom	1108	1121	postoperative
I-Symptom	1122	1134	inflammation
O	1135	1144	predicted
B-Symptom	1145	1152	retinal
I-Symptom	1153	1162	thickness
O	1163	1165	at
O	1166	1167	1
O	1168	1173	month
O	1174	1175	(
O	1175	1176	P
O	1177	1178	<
O	1179	1180	0
O	1180	1181	.
O	1181	1183	05
O	1183	1184	)
O	1184	1185	.

B-Characteristic	1186	1200	Intraoperative
I-Characteristic	1201	1212	epinephrine
I-Characteristic	1213	1216	use
O	1217	1220	was
O	1221	1231	associated
O	1232	1236	with
O	1237	1246	increased
O	1247	1260	postoperative
B-Characteristic	1261	1273	inflammation
O	1274	1275	(
O	1275	1276	P
O	1277	1278	=
O	1279	1280	0
O	1280	1281	.
O	1281	1283	02
O	1283	1284	)
O	1284	1285	.

B-Anatomy	1286	1290	Eyes
O	1291	1295	with
O	1296	1303	greater
O	1304	1313	reduction
O	1314	1316	in
B-Characteristic	1317	1320	CSF
O	1321	1322	(
O	1322	1324	or
B-Characteristic	1325	1328	CPT
O	1328	1329	)
O	1330	1334	from
O	1335	1343	baseline
O	1344	1355	experienced
O	1356	1360	more
O	1361	1366	rapid
O	1367	1373	visual
O	1374	1382	recovery
O	1383	1384	(
O	1384	1385	r
O	1386	1387	=
O	1388	1389	-
O	1389	1390	0
O	1390	1391	.
O	1391	1393	36
O	1393	1394	;
O	1395	1397	95
O	1397	1398	%
O	1399	1401	CI
O	1401	1402	,
O	1403	1404	-
O	1404	1405	0
O	1405	1406	.
O	1406	1408	61
O	1409	1411	to
O	1412	1413	-
O	1413	1414	0
O	1414	1415	.
O	1415	1417	06
O	1417	1418	;
O	1419	1420	P
O	1421	1422	=
O	1423	1424	0
O	1424	1425	.
O	1425	1427	02
O	1427	1428	)
O	1428	1429	.

B-Disease	1430	1444	Postvitrectomy
I-Disease	1445	1447	ME
O	1448	1450	is
O	1451	1457	common
O	1458	1461	and
O	1462	1468	delays
O	1469	1475	visual
O	1476	1484	recovery
O	1484	1485	.

O	1486	1492	Degree
O	1493	1495	of
B-Symptom	1496	1509	postoperative
I-Symptom	1510	1522	inflammation
O	1523	1525	is
O	1526	1528	an
O	1529	1538	important
O	1539	1543	risk
O	1544	1550	factor
O	1551	1554	for
B-Disease	1555	1557	ME
O	1558	1561	and
O	1561	1562	,
O	1563	1565	in
O	1566	1570	this
O	1571	1577	series
O	1577	1578	,
O	1579	1582	was
O	1583	1592	increased
O	1593	1595	in
O	1596	1599	the
O	1600	1607	setting
O	1608	1610	of
O	1611	1622	intraocular
O	1623	1634	epinephrine
O	1634	1635	.

O	1636	1643	Efforts
O	1644	1646	to
O	1647	1653	reduce
O	1654	1656	or
O	1657	1664	prevent
B-Symptom	1665	1677	inflammation
O	1678	1683	after
O	1684	1694	vitrectomy
O	1695	1701	should
O	1702	1704	be
O	1705	1715	beneficial
O	1716	1719	and
O	1720	1729	therefore
O	1730	1733	are
O	1734	1744	encouraged
O	1744	1745	.
